Physician profile
Victor Maevsky
NPI 1790792398
$6,687.15
in general payments reported to CMS, 2019-2025
10 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,588 · 2020: $41.85 · 2021: $75.08 · 2022: $72.30 · 2023: $1,196 · 2024: $1,041 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,532 · Travel and Lodging: $1,064 · Education: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,532.31 |
| Travel and Lodging | $1,063.94 |
| Education | $313.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,742.77 | 2021-2025 | Mo.Ma Ultra, Hawkone, Endurant Iis |
| Abbott Laboratories | $1,648.72 | 2019-2024 | Amplatzer Amulet |
| Edwards Lifesciences Corporation | $1,424.18 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $860.48 | 2019-2020 | |
| Abiomed | $605.19 | 2020-2024 | Impella |
| Shockwave Medical, INC | $155.42 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Ekos Corporation | $134.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.16 | 2025 | |
| Cerus Corporation | $47.25 | 2024 | Intercept Blood System For Platelets |
| Merck Sharp & Dohme LLC | $19.75 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Maevsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.